Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?

MLA

Mador-House, Rachel, et al. “Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?” International Journal of Neonatal Screening, vol. 7, no. 3, Aug. 2021. EBSCOhost, https://doi.org/10.3390/ijns7030055.

APA

Mador-House, R., Liu, Z., & Dyack, S. (2021). Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target? International Journal of Neonatal Screening, 7(3). https://doi.org/10.3390/ijns7030055

Chicago

Mador-House, Rachel, Zaiping Liu, and Sarah Dyack. 2021. “Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?” International Journal of Neonatal Screening 7 (3). doi:10.3390/ijns7030055.